SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 3.22 |
Enterprise Value ($M) | 10.87 |
Book Value ($M) | 3.76 |
Book Value / Share | 2.85 |
Price / Book | 0.86 |
NCAV ($M) | -7.66 |
NCAV / Share | -5.80 |
Price / NCAV | -0.42 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.60 |
Return on Assets (ROA) | -0.37 |
Return on Equity (ROE) | -0.90 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.36 |
Current Ratio | 0.58 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.11 |
Assets | 17.53 |
Liabilities | 13.77 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
777 | 8,568 | 9.07 | |
3,518 | 23,606 | 14.90 | |
6,501 | 89,508 | 7.26 | |
1,878 | 17,099 | 10.98 | |
(click for more detail) |
Similar Companies | |
---|---|
TTNP – Titan Pharmaceuticals, Inc. | UNCY – Unicycive Therapeutics, Inc. |
UPC – Universe Pharmaceuticals INC | VERU – Veru Inc. |
VKTX – Viking Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io